Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
14.44
-0.09 (-0.62%)
At close: Mar 13, 2026, 4:00 PM EDT
14.40
-0.04 (-0.28%)
After-hours: Mar 13, 2026, 7:52 PM EDT

Cellebrite DI Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
78.33-283.01-81.1120.8171.4
Depreciation & Amortization
11.8710.6110.019.197.01
Stock-Based Compensation
44.8930.581913.716.48
Other Adjustments
-8.15331.95115.63-120.31-69.51
Change in Receivables
-15.78-5.832.27-12.89-1.96
Changes in Inventories
1.630.980.24-3.68-1.8
Changes in Accounts Payable
4.942.763.69-5.474.24
Changes in Accrued Expenses
4.2517.590.73-8.855.11
Changes in Unearned Revenue
49.7722.3246.1138.9721.8
Changes in Other Operating Activities
1.84.24-14.53-10.9-6.71
Operating Cash Flow
173.54132.17102.0620.5836.05
Operating Cash Flow Growth
31.30%29.51%395.98%-42.92%-45.80%
Capital Expenditures
-13.23-8.57-5.23-6.9-5.11
Purchases of Intangible Assets
--2.04-2.69-2.19-3
Purchases of Investments
-508.23-334.79-144.32-165.36-21
Proceeds from Sale of Investments
400.66198.67129.783.2294.34
Payments for Business Acquisitions
-147.46-2.75---20
Investing Cash Flow
-268.25-149.47-22.54-91.2345.23
Issuance of Common Stock
25.0520.6621.7713.9731.6
Net Common Stock Issued (Repurchased)
25.0520.6621.7713.9731.6
Common Dividends Paid
-----100
Other Financing Activities
--0.01---
Financing Cash Flow
25.0520.6521.7713.97-68.4
Effect of Exchange Rate Changes on Cash and Cash Equivalents
2.45-1.210.59-1.64-0.75
Net Cash Flow
-69.653.35101.28-56.6812.88
Free Cash Flow
160.32123.6196.8313.6830.94
Free Cash Flow Growth
29.70%27.66%607.80%-55.79%-48.71%
FCF Margin
33.70%30.81%29.78%5.05%12.57%
Free Cash Flow Per Share
0.640.590.510.070.19
Levered Free Cash Flow
139.35-233.09-40.07133.1795.93
Unlevered Free Cash Flow
118.45108.2776.713.4136.52
Updated Feb 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q